Modern advances in genetics and biochemistry have made it possible not only to qualitatively study the pathogenesis of many diseases, but also to move one step closer to personalized medicine. In particular, this approach has become extremely relevant for oncology. The pharmacy production of anticancer drugs of YURіA-PHARM makes it possible to dose individual components of the prescription in accordance with the characteristics of the disease (genetic profile, stage) and the needs and state of the organism of each patient individually.
The production of personalized cytostatic drugs requires high-tech equipment, requires compliance with high safety standards and must be carried out by qualified specialists. Substances used by YURіА-PHARM have passed certification and comply with international quality standards.
In addition to ensuring the production itself, we conduct research into the effectiveness of new substances that can be used as components of personalized oncotherapy drugs.